Breslow thickness ≥ 0.75 mm, Clark level ≥ IV, and ulceration significantly predict SLN disease in thin melanoma. Most SLN metastases (86.2%) occur in melanomas ≥ 0.75 mm, with 6.3% of these patients having SLN disease, whereas in melanomas < 0.75 mm, SLN metastasis rates are < 5%. By using a 5% metastasis risk threshold, SLNB is indicated for melanomas ≥ 0.75 mm, but further study is needed to define indications for SLNB in melanomas < 0.75 mm.
Coping With Melanoma: Support, Emotional Concerns, and a Healthy Lifestyle
Dealing with a melanoma diagnosis can be emotionally devastating. The worries and stress associated with diagnosis and treatment can feel overwhelming. However, with the right support and careful management, it is possible to overcome these challenges and go on to live a full and fulfilling life.
